Abstract A30: Predictive and pharmacodynamic biomarkers of vantictumab (OMP-18R5; anti-Frizzled) in non-small cell lung cancer

Title
Abstract A30: Predictive and pharmacodynamic biomarkers of vantictumab (OMP-18R5; anti-Frizzled) in non-small cell lung cancer
Authors
Keywords
-
Journal
MOLECULAR CANCER THERAPEUTICS
Volume 14, Issue 12 Supplement 2, Pages A30-A30
Publisher
American Association for Cancer Research (AACR)
Online
2016-05-20
DOI
10.1158/1535-7163.targ-15-a30

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search